De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report.
نویسندگان
چکیده
152 Nefrologia 2013;33(1):134-54 and hospitalization. N Engl J Med 2004;351(13):1296-30. 2. Petri MA, Kiani AN, Post W, ChristopherStine L, Magder LS. Lupus Atherosclerosis Prevention Study (LAPS). Ann Rheum Dis 2011;70(5):760-5. 3. Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Espinosa G, Cervera R, et al. Clinical significance of adquirid activated protein C resistance in patients with systemic lupus erythematosis. Lupus 2002;11:730-5. 4. Nojima J, Kuratsune H, Suehisa E, Kawasaki T, Machii T, Kitani T, et al. Acquired activated protein C resistance is associated with the co-existence of antiprothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythemaosus. Br J Haematol 2002;118:577-83. 5. Vhan YC, Valenti D, Mansfield AO, Stansby G. Warfarin induced skin necrosis. Br J Surg 2000;87:266-72.
منابع مشابه
Dose kidney transplant nephrectomy stop disease progression in plasma exchange resistant post transplant hemolytic uremic syndrome? A case report.
BACKGROUND Two different case reports, which have been published previously, suggested that bilateral nephrectomy can improve sever and refractory hemolytic uremic syndrome (HUS) in adults without a history of transplantation. At this study, kidney transplant nephrectomy in a patient with sever post transplant HUS was investigated. CASE Patient was a 55 years old man with a single small size ...
متن کاملEarly Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome
Background Kidney transplantation is the first-line therapy for patients with end-stage renal disease since it offers greater long-term survival and improved quality of life when compared to dialysis. The advent of calcineurin inhibitor (CNI)-based maintenance immunosuppression has led to a clinically significant decline in the rate of acute rejection and better short-term graft survival rates....
متن کاملConcurrent Atypical Hemolytic Uremic Syndrome and Autoimmune Hemolytic Anemia: a case report
Background: Atypical hemolytic uremic syndrome (aHUS) is a life-threatening and scarce disorder characterized by acute renal failure and disease, non-immune microangiopathic hemolytic anemia and thrombocytopenia, leading to end-stage renal failure or death, and consequently maybe accompanying by extra renal manifestations. Case report: We reported aHUS accompanied by autoimmune hemolytic anemi...
متن کاملDevelopment of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient.
The clinical presentation of post-transplantation thrombotic microangiopathy (TMA) is variable. Often, TMA will manifest systemically as haemolytic-uraemic syndrome (HUS), with classic findings of renal failure, haemolytic anaemia, schistocytes and thrombocytopenia [1]. Localized and systemic TMA represent a spectrum of severity of the same disorder, not two different disorders with distinct pa...
متن کامل[Coronary artery disease and percutaneous coronary intervention in a set of twins].
1. Remuzzi G. Hus and TTP. Variable expression of a single entity. Kidney Int. 1997;32:292-308. 2. Mercadal L, Petitclerc T, Assogba U, Beaufils H, Deray G. Hemolytic and uremic syndrome after heart transplantation. Am J Nephrology. 2000;20:418-20. 3. Robson M, Cote I, Abbs I, Koffman G, Goldsmith D. Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentation of calcineurin-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
دوره 33 1 شماره
صفحات -
تاریخ انتشار 2013